×
Alpha Teknova Inventory 2021-2024 | TKNO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alpha Teknova inventory from 2021 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
View More
Alpha Teknova Inventory 2021-2024 | TKNO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alpha Teknova inventory from 2021 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Related Stocks
Company Name
Market
Cap
Amgen (AMGN)
$171.5B
Vertex Pharmaceuticals (VRTX)
$121.6B
Gilead Sciences (GILD)
$111.4B
Bristol Myers Squibb (BMY)
$110.2B
Regeneron Pharmaceuticals (REGN)
$93B
CSL (CSLLY)
$90B
GSK (GSK)
$76.4B
Argenex SE (ARGX)
$35.6B
Alnylam Pharmaceuticals (ALNY)
$35.3B
BioNTech SE (BNTX)
$26.5B
Biogen (BIIB)
$25.3B
Illumina (ILMN)
$23.9B
Moderna (MRNA)
$21B
BeiGene (BGNE)
$19.9B
Genmab (GMAB)
$14.9B
Incyte (INCY)
$14.7B
Exact Sciences (EXAS)
$12.9B
BioMarin Pharmaceutical (BMRN)
$12.7B
Vaxcyte (PCVX)
$12B
Bio-Techne Corp (TECH)
$11.9B
Sarepta Therapeutics (SRPT)
$11.8B
Insmed (INSM)
$11.7B
QIAGEN (QGEN)
$9.8B
Exelixis (EXEL)
$9.7B
Bio-Rad Laboratories (BIO.B)
$9.3B
Revolution Medicines (RVMD)
$9.2B
Intra-Cellular Therapies (ITCI)
$9.2B
Roivant Sciences (ROIV)
$8.6B
Viking Therapeutics (VKTX)
$8.1B
Legend Biotech (LEGN)
$8.1B